Stronger Authentication Without Compromising User Experience
MFA fatigue
Reduce needless prompts so users don’t approve attacks by habit.
Phishing replay
Stop stolen credentials and OTP replays with context-aware enforcement.
Remote & vendor risk
Enforce location, time, and device trust policies automatically.
Session blind trust
Re-check trust signals as risk changes during the session.
The reality: Even with layered MFA and policies, attackers still succeed using valid logins and session abuse—forcing a shift from stronger verification to non-replayable access outcomes.
The Compounding Risk of Identity-Based Access Failures
Avg. Security Tools
Tool sprawl increases complexity, but credential abuse remains one of the most reliable paths to access.
00
Avg. Security Tools
Less Time to Respond
Gartner predicts AI agents will reduce the time needed to exploit exposed accounts by 50% by 2027 — shrinking response windows.
00 %
Less Time to Respond
High Cost of Disruption
In pharma, access incidents don’t just trigger tickets — they trigger investigations, downtime risk, and executive scrutiny.
Why pharma is uniquely exposed
In pharmaceuticals, access is directly tied to IP protection, clinical integrity, manufacturing continuity, and regulatory confidence. Yet many security programs still rely on authentication approaches attackers can steal, intercept, or socially engineer.
-
High-value targets
Compound libraries, formulas, trial data, and regulated systems create continuous incentives for intrusion.
-
Partner-driven access
CROs, vendors, and external collaborators expand the attack surface faster than governance can keep up.
-
Audit pressure
“Valid login” incidents become compliance findings, investigations, and repeat remediation work.
-
Operational sensitivity
Access disruptions in labs and plants can affect timelines, production, and business outcomes.
-
What pharma teams are tired of
Credentials reused across labs, portals, and vendors
MFA fatigue in shared or high-pressure workflows
“Valid login” incidents that become audit explanations
Long investigations that steal time from real work
The shift: The new standard isn’t stronger verification — it’s ensuring exposed credentials and hijacked sessions cannot be replayed into access.
Why Traditional MFA and IAM Are No Longer Enough for Pharma
Pharmaceutical organizations operate in an environment where access equals value. Research data, clinical trial systems, manufacturing controls, and partner portals are prime targets for attackers — not because security teams are weak, but because credentials are routinely exposed.
Verizon and Gartner research show that most breaches today do not start with malware — they start with valid credentials. When attackers log in successfully, traditional MFA and IAM controls often cannot distinguish between a real user and a replayed or socially engineered login.
The pharma reality:
-
Credentials are reused across labs, CROs, vendors, and portals
-
MFA fatigue and push-approval attacks succeed under pressure
-
“Valid login” incidents become audit findings and investigations
-
Tool sprawl creates gaps in identity enforcement
What pharma leaders actually need
-
Authentication that remains secure even when credentials are stolen.
-
IAM controls that reduce incident likelihood — not just log activity.
-
Predictable access outcomes across R&D, trials, manufacturing, and partners.
-
Audit-defensible access decisions that don’t require post-incident explanations.
- Rainbow Secure’s approach: assume credentials will leak — and design authentication so plain password text is useless to them, while continuously verifying sessions to reduce the risk of hijacked access.
The after picture pharma leaders actually want
The goal isn’t more authentication steps. The goal is fewer emergencies. Rainbow Secure is designed so plain password text is useless to them — even if credentials leak.
- Stolen credentials stop working against protected apps
- Automated login attacks fail quietly instead of escalating
- Users stop panicking during sign-in; IT stops firefighting access
- Dark web monitoring becomes optional, not critical
- Audit narratives become simpler and more defensible
- Password reset storms and repeated lockouts
- Suspicious-login escalations that become all-hands emergencies
- Credential replay into regulated systems and the investigations that follow
- Plain-text credentials on the dark web no longer represent organizational risk as user authenticates using additioanal layers of colors, styles, formatting position and visual interaction, layers that cannot be harvested or replayed.
- Vendor access turning into your next incident headline
Where pharma teams use Rainbow Secure
Designed to reduce the chance that stolen or shared credentials lead to IP loss or compliance incidents.
R&D / IP Protection
Secure compound libraries and proprietary formulas by ensuring access requires real user intent — not just valid credentials.
What stops happening
Credential reuse, unauthorized formula access, and post-incident IP exposure investigations.
Clinical Trials (GxP/GCP)
Maintain data integrity across CROs and partners with consistent access policies and audit-ready login events.
What stops happening
Disputed access events, repeated MFA workarounds, and audit escalations tied to “valid login” misuse.
Manufacturing Access
Reduce credential-driven intrusion risk for production-related systems by strengthening authentication and governance.
What stops happening
Credential-triggered disruption, unauthorized changes, and incident response that interrupts production timelines.
Third-Party Access
Enable external collaborators without expanding risk — with controlled, auditable access patterns.
What stops happening
Vendor credential incidents, shared-account sprawl, and long investigations into who accessed what.
How Most Breaches in Regulated Industries Begin
Aggregated insights from Verizon’s Data Breach Investigations Report (DBIR) and Gartner’s security research consistently show that identity-based attacks are the most common method attackers use to gain initial access. These attacks exploit stolen credentials, weak authentication mechanisms, and poor identity governance rather than traditional system vulnerabilities.
This trend is especially pronounced in highly regulated, data-rich industries such as pharmaceuticals, where sensitive intellectual property, clinical trial data, and personal health information make identity systems a prime target. The widespread use of third-party vendors, remote access, and legacy authentication workflows further increases exposure, allowing attackers to move laterally once an identity is compromised. As a result, protecting digital identities has become a critical priority for reducing breach risk and limiting the blast radius of modern cyber incidents.
We don’t just protect access we protect scientific integrity
Pharma organizations need controls they can explain. Rainbow Secure strengthens authentication while producing evidence-friendly access records that simplify internal reviews and external audits.
- Audit-defensible authenticationAccess decisions are supported by clear event records and policy enforcement—reducing repeat explanations
during audits. - Governed third-party accessExtend strong access controls to CROs and vendors without turning the experience into friction.
- Outcome-focused securityReduce the likelihood that stolen or shared credentials lead to reportable incidents or compliance findings.
Security outcomes pharma buyers care about
Phishing replay risk
Reduced
MFA fatigue exposure
Reduced
Credential replay into regulated systems
Blocked
Audit confidence
Improved
Protect scientific integrity — not just access
When protecting intellectual property, clinical systems, and regulated operations, the priority is ensuring secure access even when credentials are compromised. Credential theft is now a common entry point, not an exception. Effective security assumes breach and prevents misuse through strong identity controls. This approach limits lateral movement, protects sensitive data, and keeps critical operations running without disruption.
Ready To Get Started ? We're Here To Help
Start your journey with us today. It’s quick, easy, and we’re here to help you every step of the way.
Let’s TalkOrganizations That Trust Rainbow Secure
